GEODE CAPITAL MANAGEMENT, LLC - TRANSCODE THERAPEUTICS INC ownership

TRANSCODE THERAPEUTICS INC's ticker is RNAZ and the CUSIP is 89357L105. A total of 14 filers reported holding TRANSCODE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of TRANSCODE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$25,641
+50176.5%
75,683
-1.1%
0.00%
Q4 2022$51
-99.9%
76,5490.0%0.00%
Q3 2022$84,000
-12.5%
76,5490.0%0.00%
Q2 2022$96,000
-53.2%
76,549
+7.4%
0.00%
Q1 2022$205,000
+13.3%
71,2720.0%0.00%
Q4 2021$181,000
+262.0%
71,272
+318.7%
0.00%
Q3 2021$50,00017,0230.00%
Other shareholders
TRANSCODE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,289,000$1,418,0000.44%
Worth Venture Partners, LLC 324,157$357,0000.22%
Redmond Asset Management, LLC 90,874$100,0000.04%
ACT CAPITAL MANAGEMENT, LLC 6,500$7,0000.01%
K.J. Harrison & Partners Inc 19,987$22,0000.01%
Shay Capital LLC 15,060$17,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 76,549$84,0000.00%
STATE STREET CORP 21,019$23,0000.00%
BlackRock Inc. 15,334$17,0000.00%
View complete list of TRANSCODE THERAPEUTICS INC shareholders